Peri-operative use of oestrogen containing medications and deep vein thrombosis - A national survey

New Zealand Medical Journal

Volumn 115, Issue 1157, 2002, Pages

  Ardern, David W ^a,c   Atkinson, Denis R ^a   Fenton, Anna J ^b  

^a HAWKE S BAY HOSPITAL   (New Zealand)

^b Middlemore Hospital ^*

^c MIDDLEMORE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT;

ARTICLE; CLINICAL PRACTICE; DEEP VEIN THROMBOSIS; DRUG WITHDRAWAL; ELECTIVE SURGERY; ESTROGEN THERAPY; HEALTH SURVEY; HUMAN; MAJOR SURGERY; MEDICOLEGAL ASPECT; NEW ZEALAND; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; POSTAL MAIL; PRACTICE GUIDELINE; PREOPERATIVE CARE; SURGEON; DRUG ADMINISTRATION; FEMALE; HORMONE SUBSTITUTION; ORTHOPEDICS; QUESTIONNAIRE; STATISTICS; THROMBOPHLEBITIS; TREATMENT WITHDRAWAL;

CONTRACEPTIVES, ORAL, COMBINED; DRUG ADMINISTRATION SCHEDULE; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; NEW ZEALAND; ORTHOPEDICS; PERIOPERATIVE CARE; PHYSICIAN'S PRACTICE PATTERNS; POPULATION SURVEILLANCE; PRACTICE GUIDELINES; QUESTIONNAIRES; THROMBOPHLEBITIS; WITHHOLDING TREATMENT;

EID: 17044454665     PISSN: 11758716     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Medsafe. An update on oral contraceptives and blood clots; June 2000. http://www.medsafe.govt.nz/cons.htm.
2. Daly E, Vessey MP, Hawkins MM et al. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996; 348: 977-80.
3. Jick H, Derby LE, Myers MW et al. Risk of hospital admission for idiopathic venous thromboembolism among users of post-menopausal oestrogens. Lancet 1996; 348: 981-3.
4. Perez Gutthann S, Garcia Rodriguez LA, Castellsague J et al. Hormone replacement therapy and risk of venous thromboembolism: population based case control study. BMJ 1997; 314: 796-800.
5. Varas Lorenzo C, Garcia Rodriguez LA, Cattaruzzi C et al. Hormone replacement therapy and the risk of hospitalisation for venous thromboembolism: a population-based study in southern Europe. Am J Epidemiol 1998; 147: 387-90.
6. Grady D, Wenger NK, Herrington D et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease - the Heart and Estrogen/Progestin Replacement Study. Ann Intern Med 2000; 132: 689-96.
7. New Ethicals Compendium 7th ed. Auckland: Adis International; 2000.
8. New Zealand Guidelines Group. The appropriate prescribing of hormone replacement therapy; May 2001. http://www.nzgg.org.nz.
9. Gallus A, Raman K, Darby T. Venous thrombosis after elective hip replacement -the influence of preventive intermittent calf compression and of surgical technique. Br J Surg 1983; 70: 17-9.
10. Stringer MD, Steadman CA, Hedges AR et al: Deep vein thrombosis after elective knee surgery. J Bone Joint Surg 1989; 71-B: 492-7.
11. Hoek JA, Nurmohamed MT, Hamelynck KJ et al. Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid. Thromb Haemost 1992; 67: 28-32.
12. North FM, Sharples K. Changes in the use of hormone replacement therapy in New Zealand from 1991-1997. NZ Med J 2001; 114: 250-3.
13. Grady D, Sawaya G. Postmenopausal hormone therapy increases risk of deep vein thrombosis and pulmonary embolism. Am J Med 1998; 105: 41-3.
14. Hulley S, Grady D, Bush T et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280: 605-13.
15. Canter RJ, Pryce J. Risk of pregnancy while waiting for an operation. BMJ 1985; 291: 516.
16. Vessey M, Mant D, Smith A, Yeates D. Oral contraceptives and venous thromboembolism: findings in a large prospective study. BMJ 1986; 292: 526.
17. Robinson GE, Burren T, Mackie IJ et al. Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgery. BMJ 1991; 302: 269-71.
18. Middeldorp S, Meijers JCM, van de Ende AE et al. Effects on coagulation of levonorgestrel- and desogestrel- containing low dose oral contraceptives: a cross-over study. Thromb Haemost 2000; 84: 4-8.
19. International Consensus Statement. Prevention of venous thromboembolism. Int Angiol 1997; 16: 3-38.
20. Royal College of Obstetricians and Gynaecologists. Report of the RCOG working party on prophylaxis against thromboembolism in gynaecology and obstetrics. London: Chameleon Press; March 1995. p14.
21. Greer IA, Walker ID. Hormone replacement therapy and venous thromboembolism. Royal College of Obstetricians and Gynaecologists Guidelines 2000; http://www.rcog.org.uk.
22. British National Formulary. 41st ed. London: British Medical Association and the Royal Pharmaceutical Society of Great Britain; 2001.
23. American College of Obstetricians and Gynecologists. Prevention of deep vein thrombosis and pulmonary embolism. ACOG practice bulletin no. 21. Washington DC: American College of Obstetricians and Gynaecologists; 2000.